Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IG3-H8213 | Human | Biotinylated Human IgG3 Fc Protein, Avitag™ (MALS verified) |  |
|
|
| IG3-MY2179 | Mouse | Monoclonal Anti-Human IgG3 Fc Antibody, Mouse IgG2a (2B7) (MALS verified) |
|
|
|
| IG3-M5214 | Mouse | Mouse IgG3 Fc Protein, Tag Free (MALS verified) |  |
|
|
| IG3-H5200 | Human | Human IgG3 Fc Protein, Tag Free (MALS & SPR verified) |  |
|
|
Human FCGRT&B2M Heterodimer Protein, His Tag (Cat. No. FCN-H52W7) captured on CM5 Chip via anti-His antibody can bind Human IgG3 Fc, Tag Free (Cat. No. IG3-H5200) with an affinity constant of 2.82 μM as determined in SPR assay (Biacore 8K) (QC tested).
Immobilized Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG3 (AS35) (Cat. No. SPD-S67) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IgG3 Fc Antibody, Mouse IgG2a (2B7) (Cat. No. IG3-MY2179) with a linear range of 0.1-2 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Imlifidase | Mac-1 | Approved | Hansamed Inc | Idefirix | EU | Rejection of renal transplantation | Hansa Biopharma Ab | 2020-08-25 | Rejection of renal transplantation; Kidney Diseases; Purpura, Thrombotic Thrombocytopenic; Rejection of organ transplantation; Renal Insufficiency, Chronic; Guillain-Barre Syndrome; Kidney Failure, Chronic | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Ricefidase | KJ-103; KJ103 | Phase 3 Clinical | Shanghai Bao Pharmaceuticals Co Ltd | Rejection of renal transplantation; Anti-Glomerular Basement Membrane Disease | Details |
| AT-02 | AT-02 | Phase 2 Clinical | Attralus Inc | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | Details |
| BHV-1300 | BHV-1300 | Phase 1 Clinical | Biohaven Pharmaceuticals Inc | Arthritis, Rheumatoid | Details |
| HNSA-5487 | HNSA 5487; HNSA-5487 | Phase 1 Clinical | Hansa Biopharma Ab | Neoplasms; Autoimmune Diseases | Details |
| Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) | Phase 1 Clinical | University Of California San Diego | Leukemia, Myeloid, Acute | Details |
This web search service is supported by Google Inc.
A-Z
